01586nas a2200217   4500000000100000008004100001260001700042653003000059653001100089653001400100653001000114653002300124653001200147653002200159100001500181245003500196300001000231490000700241520110600248022001401354       2009                            d  c2009 Jul-Sep10aDrug Therapy, Combination10aHumans10aIncidence10aIndia10aLeprostatic Agents10aleprosy10aTreatment Outcome1 aGautam V P00aTreatment of leprosy in India.  a220-40 v553 a<p>Introduction of multi-drug therapy (MDT) into the National Leprosy Eradication Program (NLEP) of India has brought a decline in both the burden of the disease and the detection of new cases in the country. Despite this success, MDT has had many problems like remarkable relapse rate, non-adherence to the MDT and the emergence of drug resistance associated with it. Moreover, there is no new MDT regimen at present, which could solve all these problems. The current situation suggests that we should look for alternative solutions in the delivery of leprosy-related services. With the introduction of Accredited Social Health Activists under the National Rural Health Mission, there is an opportunity to control some of these problems associated with MDT. Besides, District Nucleus should take initiatives and actively participate in establishment of coordination between departments of Health, Social welfare and justice, education and various non-governmental agencies working in the field of leprosy and disability in order to deliver the best of services to the persons affected by leprosy.</p>  a0972-2823